The Deipnosophist

Where the science of investing becomes an art of living

My Photo
Location: Summerlin, Nevada, United States

A private investor for 20+ years, I manage private portfolios and write about investing. You can read my market musings on three different sites: 1) The Deipnosophist, dedicated to teaching the market's processes and mechanics; 2) Investment Poetry, a subscription site dedicated to real time investment recommendations; and 3) Seeking Alpha, a combination of the other two sites with a mix of reprints from this site and all-original content. See you here, there, or the other site!

18 December 2008


No surprise to this site's regular (but few) readers that the market trades from strength to strength, and leadership gathers no moss as it, too, improves.

I mentioned health care as a leading sector, and several groups within that sector act as the market's engine to higher prices. Among the companies from the health care sector that lead the charge to higher prices is Johnson & Johnson/JNJ, one of my Core Opportunities. BRIEFING.COM reports...

Johnson & Johnson/JNJ (60.04, +1.26) provides leadership to the health care sector and the broader S&P 500.

Aside from some selling pressure in the prior session, shares of JNJ have been on an upward trend since the start of the week. The stock is up roughly 4.8% since.

Health care is now up 2.3%, which is more than any other sector. The advance is helping provide leadership to the broader market since health care is the second largest sector in the S&P 500. Health care accounts for nearly 15% of the S&P 500's total weight.
And in a possible second surprise, Johnson & Johnson/JNJ is not alone.

Full Disclosure: Long Johnson & Johnson/JNJ.
- David M Gordon / The Deipnosophist

Labels: ,

who's online